vidarabine phosphate has been researched along with Uterine Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alberts, DS; Green, S; Miller, TP; Stephens, RL; Stock-Novack, DL; Surwit, EA; Von Hoff, DD | 1 |
| Bodey, GP; Kavanagh, JJ; Krakoff, IH | 1 |
1 trial(s) available for vidarabine phosphate and Uterine Neoplasms
| Article | Year |
|---|---|
Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced endometrial cancer. A Southwest Oncology Group Study.
Topics: Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Diseases; Humans; Middle Aged; Uterine Neoplasms; Vidarabine Phosphate | 1991 |
1 other study(ies) available for vidarabine phosphate and Uterine Neoplasms
| Article | Year |
|---|---|
Phase I study of fludarabine (2-fluoro-ara-AMP).
Topics: Adult; Aged; Agranulocytosis; Antimetabolites, Antineoplastic; Arabinonucleotides; Breast Neoplasms; Choriocarcinoma; Drug Evaluation; Female; Humans; Middle Aged; Pregnancy; Rhabdomyosarcoma; Sarcoma, Ewing; Thrombocytopenia; Uterine Cervical Neoplasms; Uterine Neoplasms; Vidarabine Phosphate | 1985 |